[Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker]
- PMID: 7789707
- DOI: 10.1055/s-2007-1023300
[Value of the TAG-72 (CA 72-4) tumor marker in primary diagnosis of ovarian carcinoma. A comparison with the established CA-125 marker]
Abstract
The value of the TAG-72 (CA 72-4) serum marker in primary diagnosis was investigated in 110 patients with histologically diagnosed ovarian cancer. A reference group consisted of 103 patients with benign pelvic masses. Compared to the well-established CA-125, TAG-72 showed a low sensitivity of 42% in the detection of ovarian cancer. By contrast, when the cut-off level for TAG-72 was set at 6 U/ml, it showed a very high specificity of 99%. When the measurement of TAG-72 was combined to that of CA-125, improvements in both the specificity (as compared to a single CA-125 determination) and the sensitivity (as compared to a single TAG-72 assay) were observed. In such a combined assay, our results suggest that the best predictive value (positive and negative) was obtained if CA-125 is assigned a relatively high cut-off value (65 U/ml) in conjunction with a low cut-off level (3.2 U/ml or 4 U/ml) for TAG-72. In the present study, at threshold values of 65 U/ml respectively, a sensitivity of 86%, a specificity of 83% and a positive and negative predictive value of 85% were obtained. In mucinous carcinomas of the ovary, however, the additional TAG-72 determination did not lead to a better predictive power than did CA-125 measurement alone.
Similar articles
-
Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.Anticancer Res. 1994 Nov-Dec;14(6B):2743-6. Anticancer Res. 1994. PMID: 7532929
-
Significance of some tumor markers in differential diagnosis of ovarian tumor.Rocz Akad Med Bialymst. 1999;44:235-43. Rocz Akad Med Bialymst. 1999. PMID: 10697438
-
Predictive value of the combined serum CA 125 and TPS during chemotherapy and before second-look laparotomy in epithelial ovarian cancer.Anticancer Res. 2000 Mar-Apr;20(2B):1297-300. Anticancer Res. 2000. PMID: 10810438 Clinical Trial.
-
[Tumor markers in epithelial ovarian cancer].Minerva Ginecol. 2003 Aug;55(4):327-32. Minerva Ginecol. 2003. PMID: 14581857 Review. Italian.
-
[Ca-125 in diagnosis and monitoring of patients with ovarian cancer].Akush Ginekol (Sofiia). 2015;54(1):11-7. Akush Ginekol (Sofiia). 2015. PMID: 25909124 Review. Bulgarian.
Cited by
-
Evaluation of a novel ELISA for the tumor-associated antigen CA 72-4 in patients with ovarian cancer.Future Sci OA. 2016 Oct 12;2(4):FSO145. doi: 10.4155/fsoa-2016-0040. eCollection 2016 Dec. Future Sci OA. 2016. PMID: 28116127 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous